Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene ...

Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...

Nanoscope’s BLA has been granted rolling review by the FDA, with the first modules already submitted. The completion of the ...

Female sex hormones can significantly enhance the progression of the rare neurodegenerative eye disease retinitis pigmentosa (RP), according to a preclinical study by researchers at UT Southwestern ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

A girl from Stevenage who has an incurable eye disease has undergone a pioneering gene therapy which has allowed her to see in the dark and ...

Genetics may raise the risk of poor vision in kids, but environment often decides how early or severe it gets.

Jenny Stafford, who has retinitis pigmentosa, completed her 250th parkrun in Jersey and says the regular activity makes a huge difference to her week. | ITV News Channel ...

In her project, she will study the eye disease Retinitis Pigmentosa (RP), which is a genetic disease leading to vision loss ...

SHEBOYGAN, Wis. (WBAY) - A Sheboygan native boasts a new gold medal for rock climbing, and she is legally blind. Seneida Biendarra beat all other competitors 3 weeks ago in Innsbruck, Austria at the ...

Similar data from Social Security Scotland indicates there are now 2,010 people receiving ADP for an eye condition. An estimated 188,000 people in Scotland are affected by some form of sight loss with ...

AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...